Skip to main content

Sigma-Aldrich Prices Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich announced last night that it has priced an aggregate principal amount of $300 million of senior notes due 2020 through a public offering.

The St. Louis-based research products and chemicals firm said that it would use proceeds from the offering for general corporate purposes.

The notes have a 10-year maturity, an issue price of 99.915 percent, and a fixed rate coupon of 3.375 percent, payable semi-annually.

Sigma-Aldrich expects to complete the offering on Oct. 28.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.